What does PHARMACIE DUFOUR do?

PHARMACIE DUFOUR is a pharmacy in Nassogne. Private Limited, started on 19 June 2006, 1 establishment.

What is the address of PHARMACIE DUFOUR?

The registered office of PHARMACIE DUFOUR is located at Rue des Alliés,Forrières 4, 6953 Nassogne.

Is PHARMACIE DUFOUR still active?

Yes. According to the CBE (30 October 2026) PHARMACIE DUFOUR is active, legal situation “Normale toestand”, started on 19 June 2006.

Is PHARMACIE DUFOUR registered on Peppol?

Yes, PHARMACIE DUFOUR is registered on the Peppol network with ID 0208:0881926077.

What is the enterprise number of PHARMACIE DUFOUR?

The enterprise number of PHARMACIE DUFOUR is BE0881926077.

When was PHARMACIE DUFOUR founded?

PHARMACIE DUFOUR was founded on 19 June 2006.

Who are the directors of PHARMACIE DUFOUR?

According to the 2025 annual accounts, the directors of PHARMACIE DUFOUR are: DUFOUR INVEST SRL.

Is PHARMACIE DUFOUR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 June 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DUFOUR make in 2025?

PHARMACIE DUFOUR posted a profit after taxes of € 5,673 in financial year 2025.

What is the revenue of PHARMACIE DUFOUR?

As a small company, PHARMACIE DUFOUR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 46,598.

How much does an employee at PHARMACIE DUFOUR earn?

The average wage cost per full-time employee at PHARMACIE DUFOUR was € 72,700 in 2023: staff costs of € 79,993 for 1.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE DUFOUR have?

According to the 2025 annual accounts, PHARMACIE DUFOUR has 0.7 full-time equivalents (FTE).

PHARMACIE DUFOUR (Private Limited) - Nassogne

Dossier PHARMACIE DUFOUR, printed on 30 October 2026 from databakkes.be/en/0881926077/pharmacie-dufour. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 1.1 to 0.7.

Financials

Financial year 2025

PHARMACIE DUFOUR from Nassogne, company number BE0881926077, closed financial year 2025 with a result of € 5,673 after tax. For that financial year PHARMACIE DUFOUR recorded a gross margin of € 46,598 and equity of € 211,853. Compared with financial year 2024, the result moved from € -1,539 to € 5,673. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Healthy

€ 211,853

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 5,673

▲ still € 1,539 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 135,192

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 25,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

0.7

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 32,523

▼ 59% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,364

▼ 5% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 69,222

▲ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 7,671

▼ 81% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 123,739 Gross margin 2022: € 123,739 First fiscal year in the series	€ 104,283 Gross margin 2023: € 104,283 ▼ 16% vs 2022 (€ 123,739) Unfavourable step	€ 91,818 Gross margin 2024: € 91,818 ▼ 12% vs 2023 (€ 104,283) Unfavourable step	€ 46,598 Gross margin 2025: € 46,598 ▼ 49% vs 2024 (€ 91,818) Unfavourable step	▼ 49%
Profit after taxes	€ 9,975 Profit after taxes 2022: € 9,975 First fiscal year in the series	€ 6,596 Profit after taxes 2023: € 6,596 ▼ 34% vs 2022 (€ 9,975) Unfavourable step	€ -1,539 Profit after taxes 2024: € -1,539 ▼ € 8,135 vs 2023 (€ 6,596) Unfavourable step	€ 5,673 Profit after taxes 2025: € 5,673 ▲ € 7,211 vs 2024 (€ -1,539) Favourable step	▲ € 7,211
Equity	€ 226,122 Equity 2022: € 226,122 First fiscal year in the series	€ 232,718 Equity 2023: € 232,718 ▲ 3% vs 2022 (€ 226,122) Favourable step	€ 231,180 Equity 2024: € 231,180 ▼ 1% vs 2023 (€ 232,718) Unfavourable step	€ 211,853 Equity 2025: € 211,853 ▼ 8% vs 2024 (€ 231,180) Unfavourable step	▼ 8%
Total debts	€ 82,959 Total debts 2022: € 82,959 First fiscal year in the series	€ 42,354 Total debts 2023: € 42,354 ▼ 49% vs 2022 (€ 82,959) Favourable step	€ 106,762 Total debts 2024: € 106,762 ▲ 152% vs 2023 (€ 42,354) Unfavourable step	€ 104,640 Total debts 2025: € 104,640 ▼ 2% vs 2024 (€ 106,762) Favourable step	▼ 2%
Cash	€ 45,598 Cash 2022: € 45,598 First fiscal year in the series	€ 46,324 Cash 2023: € 46,324 ▲ 2% vs 2022 (€ 45,598) Favourable step	€ 125,732 Cash 2024: € 125,732 ▲ 171% vs 2023 (€ 46,324) Favourable step	€ 135,192 Cash 2025: € 135,192 ▲ 8% vs 2024 (€ 125,732) Favourable step	▲ 8%
Retained profit	€ 151,122 Retained profit 2022: € 151,122 First fiscal year in the series	€ 157,718 Retained profit 2023: € 157,718 ▲ 4% vs 2022 (€ 151,122) Favourable step	€ 156,180 Retained profit 2024: € 156,180 ▼ 1% vs 2023 (€ 157,718) Unfavourable step	€ 136,853 Retained profit 2025: € 136,853 ▼ 12% vs 2024 (€ 156,180) Unfavourable step	▼ 12%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 1,600) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 25,000 Dividend 2025: € 25,000 Unchanged (€ 0) Unchanged
Bank debt	€ 16,094 Bank debt 2022: € 16,094 First fiscal year in the series	€ 9,748 Bank debt 2023: € 9,748 ▼ 39% vs 2022 (€ 16,094) Favourable step	€ 3,281 Bank debt 2024: € 3,281 ▼ 66% vs 2023 (€ 9,748) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 3,281) Favourable step	▼ 100%
Balance sheet total	€ 309,081 Balance sheet total 2022: € 309,081 First fiscal year in the series	€ 275,072 Balance sheet total 2023: € 275,072 ▼ 11% vs 2022 (€ 309,081) Unchanged	€ 337,941 Balance sheet total 2024: € 337,941 ▲ 23% vs 2023 (€ 275,072) Unchanged	€ 316,492 Balance sheet total 2025: € 316,492 ▼ 6% vs 2024 (€ 337,941) Unchanged	▼ 6%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	1.1 Employees (FTE) 2023: 1.1 ▼ 0.5 vs 2022 (1.6) Unchanged	0.8 Employees (FTE) 2024: 0.8 ▼ 0.3 vs 2023 (1.1) Unchanged	0.7 Employees (FTE) 2025: 0.7 ▼ 0.1 vs 2024 (0.8) Unchanged	▼ 0.1

Key figures of PHARMACIE DUFOUR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DUFOUR?

What happened at PHARMACIE DUFOUR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: profit of € 5,673. Source: NBB ↗
Jun 19, 2006 Start of the company according to the CBE. KBO
Jun 15, 2006 New establishment in Nassogne. KBO

In short

From € 9,975 profit in 2022 to € 5,673 profit in 2025.

Paid € 7,923 in corporate taxes since 2022.

Best year ever: 2022, with € 9,975 profit.

On average € 94,800 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

DUFOUR INVEST 50%

The stake of DUFOUR INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE DUFOUR

Behind PHARMACIE DUFOUR is DUFOUR INVEST SRL. The shares are held by DUFOUR INVEST (50%).

Directors

According to the 2025 annual accounts

DUFOUR INVEST SRL

Director · represented by Benoit DUFOUR

Shareholders

DUFOUR INVEST

50%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Alliés,Forrières 4

6953 Nassogne

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

DUFOUR INVEST same network

€ 30,743 gross margin · 2025

GROUPE DUFOUR

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0881.926.077

VAT number

BE 0881.926.077

Registered office

Rue des Alliés,Forrières 4, 6953 Nassogne

Names & denominations

PHARMACIE DUFOUR

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

19 June 2006

Peppol

Active · Active since 18 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE DUFOUR

Warning lights

Financials

What happened to PHARMACIE DUFOUR?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions